AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why

Company Performance - AngioDynamics (ANGO) stock closed at $6.09, reflecting a -0.98% change from the previous day, underperforming the S&P 500 which gained 0.57% [1] - Over the last month, AngioDynamics shares increased by 1.49%, lagging behind the Medical sector's gain of 2.05% and the S&P 500's gain of 5.07% [1] - The upcoming earnings release is anticipated, with projected earnings per share (EPS) of -$0.12, indicating a 300% decrease from the same quarter last year, and expected revenue of $78.23 million, a 3.08% decline year-over-year [1] Full Year Estimates - For the full year, analysts expect earnings of -$0.39 per share and revenue of $320.79 million, representing changes of -550% and -5.3% from the previous year [2] - Recent changes to analyst estimates may reflect short-term business dynamics, with positive adjustments indicating a favorable outlook on the company's health and profitability [2] Zacks Rank and Industry Performance - The Zacks Rank system rates AngioDynamics at 4 (Sell), with the consensus EPS estimate remaining unchanged over the last 30 days [3] - The Medical - Instruments industry, part of the Medical sector, holds a Zacks Industry Rank of 158, placing it in the bottom 38% of over 250 industries [3] - The Zacks Industry Rank is based on the average Zacks Rank of individual stocks, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [3]